Stay updated on Anti-IgE MAb in Allergic Asthma Clinical Trial
Sign up to get notified when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.

Latest updates to the Anti-IgE MAb in Allergic Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s display/release revision label was updated from v3.5.2 to v3.5.3, reflecting a site/system version change rather than an update to the clinical trial record content.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label updated to v3.5.0 from v3.4.3. No changes to the study details or other content on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedFrontend updated from v3.4.2 to v3.4.3. No changes to study content or data are visible on the page.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice and the prior Revision: v3.4.1 line were removed.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a 2026 publication: Lai K, et al. Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial. Allergy Asthma Immunol Res. 2026 Jan;18(1):39-54. Removed the earlier 2025 ahead-of-print citation and updated the page to Revision: v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Anti-IgE MAb in Allergic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.